New Issue: Science’s Impossible Questions. Read Now

Nano-Size Germ Killers

Tiny knives could be important weapons against superbugs

Join Our Community of Science Lovers!

DRUG-RESISTANT TUBERCULOSIS IS ROARING through Europe, according to the World Health Organization. Treatment options are few—antibiotics do not work on these highly evolved strains—and about 50 percent of people who contract the disease will die from it. The grim situation mirrors the fight against other drug-resistant diseases such as MRSA, a staph infection that claims 19,000 lives in the U.S. every year.

Hope comes in the form of a nanotech knife. Scientists working at IBM Research– Almaden have designed a nanoparticle capable of utterly destroying bacterial cells by piercing their membranes.

The nanoparticles' shells have a positive charge, which binds them to negatively charged bacterial membranes. “The particle comes in, attaches, and turns itself inside out and drills into the membrane,” says Jim Hedrick, an IBM materials scientist working on the project with collaborators at Singapore's Institute of Bioengineering and Nanotechnology. Without an intact membrane, the bacterium shrivels away like a punctured balloon. The nanoparticles are harmless to humans—they do not touch red blood cells, for instance—because human cell membranes do not have the same electrical charge that bacterial membranes do. After the nanostructures have done their job, enzymes break them down, and the body flushes them out.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Hedrick hopes to see human trials of the nanoparticles in the next few years. If the approach holds up, doctors could squirt nanoparticle-infused gels and lotions onto hospital patients' skin, warding off MRSA infections. Or workers could inject the particles into the bloodstream to halt systemic drug-resistant organisms, such as streptococci, which can cause sepsis and death. Even if it succeeds, such a treatment would have to overcome any unease over the idea of nanotech drills in the bloodstream. But the nastiest bacteria on the planet won't succumb easily.

Elizabeth Svoboda is based in San Jose, Calif., and author of What Makes a Hero?: The Surprising Science of Selflessness (Current, 2013). She is working on a book about the science of setting a sustainable pace in an overclocked world.

More by Elizabeth Svoboda
Scientific American Magazine Vol 305 Issue 6This article was published with the title “Nano-Size Germ Killers” in Scientific American Magazine Vol. 305 No. 6 (), p. 51
doi:10.1038/scientificamerican1211-51

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe